Cannara Biotech, Inc. (LOVE) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cannara Biotech, Inc.

Organto Foods, Inc.

BioHarvest Sciences, Inc.

Aurora Cannabis, Inc.

Jushi Holdings, Inc.

iAnthus Capital Holdings, Inc.

4Front Ventures Corp.

Planet 13 Holdings, Inc.

OrganiGram Holdings, Inc.

Ascend Wellness Holdings, Inc.

Glass House Brands, Inc.

Why is Cannara Biotech, Inc. ?

Positive results in May 25

OPERATING CASH FLOW(Y) Highest at CAD 16.8 MM
ROCE(HY) Highest at 17.21%
NET SALES(Q) Highest at CAD 27.33 MM

With ROE of -10.12%, it has a very attractive valuation with a 1.58 Price to Book Value

Over the past year, while the stock has generated a return of 116.88%, its profits have risen by 44.7%

Market Beating Performance

The stock has generated a return of 116.88% in the last 1 year, much higher than market (S&P/TSX 60) returns of 19.10%

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Cannara Biotech, Inc. should be less than 10%
Overall Portfolio exposure to Other Agricultural Products should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Other Agricultural Products)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Cannara Biotech, Inc. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Cannara Biotech, Inc.

116.88%

2.12

63.65%

S&P/TSX 60

19.1%

1.25

15.27%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

109.97%

EBIT Growth (5y)

3.96%

EBIT to Interest (avg)

-2.93

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.46

Sales to Capital Employed (avg)

0.56

Tax Ratio

1.39%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.58

EV to EBIT

-19.68

EV to EBITDA

-56.04

EV to Capital Employed

1.44

EV to Sales

1.84

PEG Ratio

Dividend Yield

ROCE (Latest)

-7.30%

ROE (Latest)

-10.12%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bearish

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

25What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CAD 16.8 MM

ROCE(HY)

Highest at 17.21%

NET SALES(Q)

Highest at CAD 27.33 MM

OPERATING PROFIT(Q)

Highest at CAD 0.69 MM

OPERATING PROFIT MARGIN(Q)

Highest at 2.53 %

NET PROFIT(Q)

Highest at CAD -1.1 MM

RAW MATERIAL COST(Y)

Fallen by -1,952.22% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at 33.53 %

PRE-TAX PROFIT(Q)

Highest at CAD -1.54 MM

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for Cannara Biotech, Inc.

Operating Cash Flow

Highest at CAD 16.8 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CAD MM)

Net Sales

Highest at CAD 27.33 MM and Grown

In each period in the last five periods

MOJO Watch

Near term sales trend is very positive

Net Sales (CAD MM)

Operating Profit

Highest at CAD 0.69 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite positive

Operating Profit (CAD MM)

Operating Profit Margin

Highest at 2.53 % and Grown

In each period in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Net Profit

Highest at CAD -1.1 MM and Grown

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CAD MM)

Pre-Tax Profit

Highest at CAD -1.54 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Pre-Tax Profit

At CAD -1.54 MM has Grown at 63.47%

over average net sales of the previous four periods of CAD -4.23 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CAD MM)

Net Profit

At CAD -1.1 MM has Grown at 66.54%

over average net sales of the previous four periods of CAD -3.3 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CAD MM)

Debt-Equity Ratio

Lowest at 33.53 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Raw Material Cost

Fallen by -1,952.22% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales